Candriam Equities L Oncology Impact R-H/ LU1864483083 /
| NAV06/06/2024 | Diferencia+0.6500 | Tipo de beneficio | Enfoque de la inversión | Sociedad de fondos |
|---|---|---|---|---|
| 194.0700EUR | +0.34% | reinvestment | Equity Worldwide | Candriam ▶ |
Rendimiento mensual
| ene. | feb. | mar. | abr. | may. | jun. | jul. | ago. | sep. | oct. | nov. | dic. | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021 | - | - | - | - | - | - | - | - | - | - | - | 3.80 | - |
| 2022 | -10.61 | -1.92 | 4.33 | -6.01 | -1.54 | -0.31 | 4.18 | -3.41 | -5.17 | 6.64 | 5.71 | -3.82 | -12.68% |
| 2023 | 1.90 | -4.09 | 1.15 | 2.65 | -2.80 | -0.13 | 0.71 | -2.23 | -5.41 | -6.53 | 8.95 | 5.51 | -1.42% |
| 2024 | 1.23 | 3.97 | 1.35 | -3.54 | 2.29 | 2.48 | - | - | - | - | - | - | - |
Valores estimados
| Año hasta la fecha | 6 Meses | Promedio móvil | 3 Años | 5 Años | |
|---|---|---|---|---|---|
| Volatilidad | 10.71% | 10.95% | 11.66% | -% | -% |
| Índice de Sharpe | 1.45 | 2.17 | 0.15 | - | - |
| El mes mejor | +5.51% | +5.51% | +8.95% | +8.95% | - |
| El mes peor | -3.54% | -3.54% | -6.53% | -10.61% | - |
| Pérdida máxima | -6.97% | -6.97% | -16.11% | - | - |
| Rendimiento superior | - | - | - | - | - |
Todas las cotizaciones en EUR
Tramos
| Nombre | Tipo de beneficio | Prec. de rescate | Promedio móvil | 3 Años | |
|---|---|---|---|---|---|
| Candriam Equities L Oncology Imp... | reinvestment | 2,402.3501 | +8.18% | +4.99% | |
| Candriam Equities L Oncology Imp... | reinvestment | 2,567.2300 | +8.32% | +5.38% | |
| Candriam Equities L Oncology Imp... | reinvestment | 207.7400 | +4.62% | -5.87% | |
| Candriam Equities L Oncology Imp... | reinvestment | 2,235.0200 | +4.75% | +15.35% | |
| Candriam Equities L Oncology Imp... | paying dividend | 1,611.9800 | +7.83% | +3.98% | |
| Candriam Equities L Oncology Imp... | reinvestment | 245.2300 | +4.97% | +13.24% | |
| Candriam Equities L Oncology Imp... | paying dividend | 236.2600 | +6.82% | +1.10% | |
| Candriam Equities L Oncology Imp... | paying dividend | 191.3900 | +7.73% | +3.67% | |
| Candriam Equities L Oncology Imp... | paying dividend | 20,691.0000 | +2.80% | +0.83% | |
| Candriam Equities L Oncology Imp... | reinvestment | 158.1100 | +4.63% | +14.96% | |
| Candriam Equities L Oncology Imp... | reinvestment | 2,113.1299 | +5.61% | -3.17% | |
| Candriam Equities L Oncology Imp... | reinvestment | 259.9500 | +5.87% | +16.14% | |
| Candriam Equities L Oncology Imp... | reinvestment | 207.1800 | +4.19% | -6.98% | |
| Candriam Equities L Oncology Imp... | reinvestment | 286.9900 | +7.72% | +3.66% | |
| Candriam Equities L Oncology Imp... | reinvestment | 194.0700 | +5.49% | - | |
| Candriam Equities L Oncology Imp... | reinvestment | 1,843.8000 | +5.09% | - | |
| Candriam Equities L Oncology Imp... | reinvestment | 2,875.2300 | +7.38% | +3.61% | |
| Candriam Equities L Oncology Imp... | reinvestment | 157.6200 | - | - | |
| Candriam Equities L Oncology Imp... | reinvestment | 273.5400 | +6.37% | +0.73% |
Performance
| Año hasta la fecha | +7.85% | ||
|---|---|---|---|
| 6 Meses | +12.90% | ||
| Promedio móvil | +5.49% | ||
| 3 Años | - | ||
| 5 Años | - | ||
| 10 Años | - | ||
| Desde el principio | -5.78% | ||
| Año | |||
| 2023 | -1.42% | ||
| 2022 | -12.68% | ||
